Understanding how a specific protein helps the urethra close properly
Defining the role of Sf1 in urethral closure
This research explores how certain cells and hormones work together to ensure the urethra closes correctly during development, aiming to understand why birth defects like hypospadias occur.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-11131190 on NIH RePORTER |
What this research studies
Hypospadias is a common birth defect affecting nearly 1% of newborn boys, where the urethra does not exit at the tip of the penis. The cause for about 70% of these cases remains unknown. Normal penis development and proper urethral closure depend on male hormones, called androgens, and specific cell communication. This project focuses on a newly discovered group of cells in the penis, called SF1+ cells, which appear to be crucial for the urethra to close correctly. We aim to understand the exact role of these SF1+ cells, which both produce and respond to androgens, in preventing hypospadias.
Who could benefit from this research
Good fit: This foundational research is relevant for newborn boys affected by hypospadias, particularly those whose condition has no clear cause.
Not a fit: Patients whose hypospadias is caused by known genetic factors or other clear environmental exposures may not directly benefit from this specific line of inquiry.
Why it matters
Potential benefit: If successful, this work could help us better understand the causes of hypospadias and potentially lead to new ways to prevent or treat this common birth defect.
How similar studies have performed: This research explores a newly discovered cell population, making this specific approach novel and previously untested in this context.
Where this research is happening
Columbia, United States
- University of Missouri-Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Amato, Ciro Maurizio — University of Missouri-Columbia
- Study coordinator: Amato, Ciro Maurizio
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.